Swedbank Robur Medica
- Namn
- Swedbank Robur Medica
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- 2020-06-30
- Fondförmögenhet
- 10 473 743 068 SEK
- Likvida medel
- 476 510 167 SEK
- Övriga tillgångar och skulder
- 21 508 893 SEK
- Antal innehav
- 67
- Aktiv risk
- 4,06
- Standardavvikelse 24 månader
- 17,15
- Jämförelseindex
- MSCI World Health Care 10/40 Net
- Förvaltningsavgift
- 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| United Health | 754 187 183 SEK | 7,20% | Health Care |
| Roche | 579 800 082 SEK | 5,54% | Health Care |
| Merck | 508 446 447 SEK | 4,85% | Health Care |
| Sanofi | 466 498 933 SEK | 4,45% | Health Care |
| Thermo Fisher Scientific | 411 332 175 SEK | 3,93% | Health Care |
| Abbott Laboratories | 409 382 057 SEK | 3,91% | Health Care |
| AstraZeneca | 402 173 822 SEK | 3,84% | Health Care |
| Centene | 386 198 802 SEK | 3,69% | Health Care |
| Takeda Pharmaceutical | 333 034 895 SEK | 3,18% | Health Care |
| Novo Nordisk | 311 090 497 SEK | 2,97% | Health Care |
| Alexion Pharmaceuticals | 301 428 935 SEK | 2,88% | Health Care |
| Vertex Pharmaceuticals | 288 539 653 SEK | 2,75% | Health Care |
| Horizon Therapeutics | 249 953 661 SEK | 2,39% | Health Care |
| Intuitive Surgical | 223 224 227 SEK | 2,13% | Health Care |
| Amgen | 220 959 442 SEK | 2,11% | Health Care |
| Mylan | 215 728 876 SEK | 2,06% | Health Care |
| Edward Lifesciences | 208 356 746 SEK | 1,99% | Health Care |
| Livanova | 201 346 671 SEK | 1,92% | Health Care |
| Exelixis | 184 727 670 SEK | 1,76% | Health Care |
| IQVIA | 180 262 001 SEK | 1,72% | Health Care |
| UCB | 177 766 339 SEK | 1,70% | Health Care |
| Swedish Orphan Biovitrum | 166 470 000 SEK | 1,59% | Health Care |
| Hologic | 159 677 970 SEK | 1,52% | Health Care |
| Eli Lilly | 147 521 934 SEK | 1,41% | Health Care |
| Ionis Pharmaceuticals | 143 570 795 SEK | 1,37% | Health Care |
Branscher
Källa: Finansinspektionen.